Antonini TM et al. |
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation. |
2015 |
AIDS |
pmid:25387314
|
Nowak P et al. |
Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection. |
2003 |
AIDS Res. Hum. Retroviruses |
pmid:12581512
|
Sklar EM |
Post-transplant neurotoxicity: what role do calcineurin inhibitors actually play? |
2006 |
AJNR Am J Neuroradiol |
pmid:16971594
|
Bargalló N et al. |
Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy. |
2000 |
AJNR Am J Neuroradiol |
pmid:10730638
|
Bartynski WS et al. |
Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. |
2001 Nov-Dec |
AJNR Am J Neuroradiol |
pmid:11733324
|
Bartynski WS et al. |
Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. |
2004 |
AJNR Am J Neuroradiol |
pmid:14970028
|
Bartynski WS et al. |
Posterior reversible encephalopathy syndrome after solid organ transplantation. |
2008 |
AJNR Am J Neuroradiol |
pmid:18272559
|
Schuuring J et al. |
Severe tacrolimus leukoencephalopathy after liver transplantation. |
2003 Nov-Dec |
AJNR Am J Neuroradiol |
pmid:14625238
|
Oliverio PJ et al. |
Reversible tacrolimus-induced neurotoxicity isolated to the brain stem. |
2000 |
AJNR Am J Neuroradiol |
pmid:10954277
|
Appignani BA et al. |
Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. |
1996 |
AJR Am J Roentgenol |
pmid:8623651
|
Ierardi E et al. |
Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11207512
|
Firpi RJ et al. |
Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15113371
|
Hisanaga Y et al. |
Implication of nitric oxide synthase activity in the genesis of water immersion stress-induced gastric lesions in rats: the protective effects of FK506. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971291
|
Trotter JF et al. |
Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15963078
|
Nakase H et al. |
Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis? |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21198700
|
Hoshino H et al. |
Effects of FK506 on an experimental model of colitis in rats. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7544633
|
Lawrance IC and Copeland TS |
Rectal tacrolimus in the treatment of resistant ulcerative proctitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18761706
|
Liberal R et al. |
Expert clinical management of autoimmune hepatitis in the real world. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28004405
|
Segal JP et al. |
Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28008631
|
Yamamoto T et al. |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040167
|